Welcome to the e-CCO Library!

P229: The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Magro1,2,3, C. Rocha4,5, A.I. Vieira6, H. T. Sousa7, I. Rosa8, S. Lopes9, J. Carvalho10, C.C. Dias11,12, J. Afonso1,3*

Created: Thursday, 21 February 2019, 9:14 AM
P229: The relationship between computed tomography enterography findings and levels of faecal biomarkers in patients with small bowel Crohn’s disease: A prospective study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Shimoyama*1, T. Yamamoto1, S. Umegae1, K. Matsumoto1

Created: Friday, 22 February 2019, 9:41 AM
P230 Health-related quality of life in adolescents and young adults (AYA) with inflammatory bowel disease and its correlations with demographic, clinical, laboratory and therapeutic evaluations
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Oba1, M. Deboni1, R. Toma1, C. Sobrado2, M. Azevedo3, A. Carlos3, M. Borba2, A. Damião3, F. Carrilho3, C. Silva4

Created: Thursday, 30 January 2020, 10:12 AM
P230: A first pregnancy seems associated with a positive effect on the course of inflammatory bowel disease: Data from a prospective pregnancy cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. van der Giessen*, S. Kanis, G. Fuhler, C. van der Woude

Created: Thursday, 21 February 2019, 9:14 AM
P230: Adalimumab in Crohn's disease is protective against periodontitis based on a validated oral health questionnaire
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saravanapavan, H.(1,2)*;Rath, S.(1,2);Inniss, S.(1,2);Ong, M.(1);Sabalić, M.(3);D'Aiuto, F.(3);Rahman, F.(1,2);Smith, A.M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P230: Development of a Japanese version of the IBD Self-Efficacy Scale and evaluation of its current status in Japan
Year: 2021
Source: ECCO'21 Virtual
Authors: Tanaka, M.(1);Kawakami, A.(1);Sakagami, K.(2);Terai, T.(3);Ito, H.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P230: Elevated angiopoietins independent of TNF α regulation appear to play a key role in immune mediated angiogenesis in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Hussey*1, G. Holleran1, K. Grooteman2, S. Smith3, D. McNamara1

Created: Friday, 22 February 2019, 9:49 AM
P230: Methotrexate in the treatment of Crohn's disease: a Portuguese real-life single center experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Peixoto A., Silva M., Morais R., Liberal R., Lopes S., Magro F., Macedo G.

Created: Wednesday, 20 February 2019, 10:36 AM
P230: Prediction of loss of response to anti-TNF therapy using SES-CD in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Fuyuno*1, T. Torisu1, A. Hirano1, S. Fujioka1,2, J. Umeno1, T. Moriyama1,3, T. Kitazono1, M. Esaki4

Created: Friday, 22 February 2019, 9:41 AM
P230: Ultrasonography-based and Magnetic Resonance-based Lémann Index: two sides of the same coin
Year: 2022
Source: ECCO'22
Authors: Allocca , M.(1);Dell'Avalle , C.(2);Radice , S.(1);Bonifacio , C.(3);Furfaro , F.(4);Zilli , A.(1);D'Amico , F.(1);Peyrin-Biroulet , L.(5);Danese , S.(1);Fiorino , G.(1);
Created: Friday, 11 February 2022, 3:52 PM
P231 Epidemiological profile and long-term outcomes from a large PSC-IBD cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.E. Caon, C. Martins, M. Cruz, L. Leite Barros, M. Azevedo, N. Queiroz, A. Carlos, L. Milane, J. Oba, M. Braga, A. Sipahi, A. Damião, E. Cançado

Created: Thursday, 30 January 2020, 10:12 AM
P231: Backgrounds and D-dimer on admission are useful factors for predicting venous thromboembolic complications in hospitalized patients with inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ohta Y., Taida T., Nakagawa T., Hamanaka S., Koseki H., Okimoto K., Maruoka D., Matsumura T., Arai M., Katsuno T.

Created: Wednesday, 20 February 2019, 10:36 AM
P231: CECDAIic: a new score for panenteric evaluation in Crohn’s disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Arieira*1,2,3, R. Magalhães1,2,3, F. Dias de Castro1,2,3, P. Boal Carvalho1,2,3, B. Rosa1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P231: CRP/Albumin ratio associated with disease activity in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Sayar, R. Kahraman*, K. Kürbüz, R. Atalay, R. Atalay, O. Ozturk, H.L. Doganay, Z. Calışkan, K. Ozdil

Created: Thursday, 21 February 2019, 9:14 AM
P231: Development of a small bowel capsule endoscopic index of severity in patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Bourreille*1, A. Attar2, V. Maunoury3, M. Simon4, A. Aubourg5, M. Fumery6, J.-M. Reimund7, C. Reenaers8, I. Nion-Larmurier2, B. Bonaz9, J. Filippi10, O. Dewit11, X. Dray2, J. Moreau12, R. Altwegg13, X. Roblin14, C. Stefanescu2, J.-y. Mary15

Created: Friday, 22 February 2019, 9:49 AM
P231: Emergency Colectomy for IBD Is Not Associated with Increased Risk of Postoperative Infection, Reoperation or Readmission
Year: 2022
Source: ECCO'22
Authors: Connelly, T.(1);Clancy, C.(1);Cheong, J.Y.(1);Jia, X.(1);Kessler, H.(1);Valente, M.(1);HolubarMD- MS, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P231: Impact of age of Inflammatory Bowel Disease diagnosis on disease phenotype and severity in elderly patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Orfanoudaki, E.(1)*;Chlorakis, G.(1);Foteinogiannopoulou, K.(1);Drygiannakis, I.(1);Theodoraki, E.(1);Tsafaridou, M.(1);Koutroubakis, I.(1);
Created: Friday, 14 July 2023, 10:48 AM
P231: Work productivity loss in perianal crohn's disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Jlassi, H.(1);Sabbah, M.(1);Bellil, N.(1);Trad, D.(1);Ouakaa, A.(1);Bibani, N.(1);Gargouri, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P232 In suspected small bowel Crohn’s disease: Clinical impact of using capsule endoscopy to make decisions
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R.A. Gonzalez, E.J. Gómez, L. Pereyra, J.M. Mella, G.N. Panigadi, C. Fischer, M. Roel, D. Cimmino, S. Pedreira, L.A. Boerr

Created: Thursday, 30 January 2020, 10:12 AM
P232: Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Kaazan, P.(1);li, T.(2);seow, W.(3);bednarz, J.(4);pipicella, J.(2);Ng, W.(2);Wiiliams , A.J.(2);Connor , S.(2);Andrews, J.(5);
Created: Wednesday, 2 June 2021, 4:12 PM